Jilna Dilip Shukla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jilna Dilip Shukla has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Andile Mtshali
School of Laboratory Medicine and Medical Science, Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa
1 shared publication - Birgitte Jyding Vennervald
Department of Veterinary and Animal Sciences, University of Copenhagen, DYRLAEGEVEJ100.2, DK-1870 Frederiksberg C, Denmark
1 shared publication - Elisabeth Kleppa
Oslo University Hospital
1 shared publication - Eyrun Floerecke Kjetland
Norwegian Center for Imported and Tropical Diseases, Department of Infectious Diseases Ullevaal/Department of Global Health Oslo University Hospital Oslo Norway
1 shared publication - Motshedisi Sebitloane
Discipline of Obstetrics and Gynaecology, School of Clinical Medicine, University of KwaZulu-Natal, Durban 4002, South Africa
1 shared publication - Myra Taylor
School of Nursing and Public Health, Discipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa
1 shared publication
Latest Publications
- Open Access
Female genital schistosomiasis and reproductive tract infections. A cross-sectional study in rural adolescents in South Africa
Background and objectives: The aim of the current study was to establish the relative prevalences of Female Genital Schistosomiasis (FGS) and sexually transmitted infections (STIs). We hypothesised that due to the use of syndromic management for STIs it is possible that FGS is being misdiagnosed and mismanaged as an STI. We therefore wanted to examine the relationship between FGS and the individual STIs in schistosomiasis endemic areas. Methods: Between 2011 and 2013, a cross-sectional study was performed in 32 randomly selected secondary schools in rural KwaZulu-Natal, South Africa, where each school had at least 300 pupils. In a research clinic, FGS diagnosis, STI testing, and face-to-face interviews were performed in sexually active, young women aged 16 – 22 years. Results: FGS was the second most prevalent current genital infection (23%). There were significantly more women who had presented FGS among those who had detectable urinary schistosomiasis (35%), compared to those without (19%, p< 0.001). In the FGS positive group 35% were positive for HPV infection, compared to 24 % in the FGS negative group (p=0.010). In the FGS positive group 37% were sero-positive for HSV infection, compared to 30% in the FGS negative group (p=0.079). There were significantly fewer chlamydia infections amongst women with FGS (20%, p=0.018) compared with those who did not have FGS (28%). Conclusions: FGS was the second most common genital infection after HSV but the two were not significantly associated. HPV infection was significantly associated with FGS. Surprisingly Chlamydia infection were negatively associated with FGS. The results show the importance of the inclusion of FGS in the management protocols for genital infections in areas endemic for urinary schistosomiasis, and highlight the importance for more research on suitable differential diagnostic tools and disease management. Key messages box: FGS was the second most common genital infection in this rural population after HSV. FGS was positively associated with HPV. FGS was negatively associated with genital chlamydia infections. FGS should be included in the syndromic management of genital infections.
Open AccessFemale genital schistosomiasis and reproductive tract infections. A cross-sectional study in rural adolescents in South Africa
Background and objectives: The aim of the current study was to establish the relative prevalences of Female Genital Schistosomiasis (FGS) and sexually transmitted infections (STIs). We hypothesised that due to the use of syndromic management for STIs it is possible that FGS is being misdiagnosed and mismanaged as an STI. We therefore wanted to examine the relationship between FGS and the individual STIs in schistosomiasis endemic areas. Methods: Between 2011 and 2013, a cross-sectional study was performed in 32 randomly selected secondary schools in rural KwaZulu-Natal, South Africa, where each school had at least 300 pupils. In a research clinic, FGS diagnosis, STI testing, and face-to-face interviews were performed in sexually active, young women aged 16 – 22 years. Results: FGS was the second most prevalent current genital infection (23%). There were significantly more women who had presented FGS among those who had detectable urinary schistosomiasis (35%), compared to those without (19%, p< 0.001). In the FGS positive group 35% were positive for HPV infection, compared to 24 % in the FGS negative group (p=0.010). In the FGS positive group 37% were sero-positive for HSV infection, compared to 30% in the FGS negative group (p=0.079). There were significantly fewer chlamydia infections amongst women with FGS (20%, p=0.018) compared with those who did not have FGS (28%). Conclusions: FGS was the second most common genital infection after HSV but the two were not significantly associated. HPV infection was significantly associated with FGS. Surprisingly Chlamydia infection were negatively associated with FGS. The results show the importance of the inclusion of FGS in the management protocols for genital infections in areas endemic for urinary schistosomiasis, and highlight the importance for more research on suitable differential diagnostic tools and disease management. Key messages box: FGS was the second most common genital infection in this rural population after HSV. FGS was positively associated with HPV. FGS was negatively associated with genital chlamydia infections. FGS should be included in the syndromic management of genital infections.